Does neoadjuvant therapy for esophageal cancer increase postoperative morbidity or mortality? - Wikidata - wikimedia - TriplyDB

Does neoadjuvant therapy for esophageal cancer increase postoperative morbidity or mortality?

Does neoadjuvant therapy for esophageal cancer increase postoperative morbidity or mortality?

http://www.wikidata.org/entity/Q35072610

about

Impact of Neoadjuvant Chemoradiation on Short-Term Outcomes for Esophageal Squamous Cell Carcinoma Patients: A Meta-analysis.Does neoadjuvant chemotherapy affect morbidity, mortality, reoperations, or readmissions in patients undergoing lumpectomy or mastectomy for breast cancer?Neoadjuvant versus adjuvant chemoradiation for stage II-III esophageal squamous cell carcinoma: a single institution experience.Perioperative outcomes of esophageal cancer surgery in a mid-volume institution in the era of centralization.Esophageal Cancer Treatment Is Underutilized Among Elderly Patients in the USA.Salvage esophagectomy: safe therapeutic strategy?[Timing of esophagectomy in multimodal therapy of esophageal cancer: Impact of time interval between neoadjuvant therapy and surgery on outcome and response].Monitoring sputum culture in resected esophageal cancer patients with preoperative treatment.

P2860

Q36045600-AF609CBE-E06F-4F83-B501-26BACD9DD4B4 Q37626892-689641D8-C238-4B66-AF6F-D23728D7799E Q39285940-36F6DF28-A6CB-4835-8C55-CA0EDAF70F30 Q39582802-6E636F21-5E92-4012-8AFF-5A83FDDBD7CD Q40621386-D8024374-B1F1-4BEE-BA31-4029BB1CBA59 Q41202610-5A38F113-3939-4BA9-A8AB-D6794ABD3324 Q44802763-1207B011-E42F-4D25-AD26-DB4B45AA4311 Q46310733-0BF28D80-5CE2-42DC-AB53-6C7EA9693B18

P2860

Does neoadjuvant therapy for esophageal cancer increase postoperative morbidity or mortality?

http://www.wikidata.org/entity/Q35072610

description

2014 nî lūn-bûn

@nan

2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Does neoadjuvant therapy for e ...... rative morbidity or mortality?

@ast

Does neoadjuvant therapy for e ...... rative morbidity or mortality?

@en

type

label

Does neoadjuvant therapy for e ...... rative morbidity or mortality?

@ast

Does neoadjuvant therapy for e ...... rative morbidity or mortality?

@en

prefLabel

Does neoadjuvant therapy for e ...... rative morbidity or mortality?

@ast

Does neoadjuvant therapy for e ...... rative morbidity or mortality?

@en

P1433

Q35072610-E5BBCD0E-D6DB-45F8-8C4D-28183BD9F6AF

P1476

Q35072610-E18D7C7A-80F5-4C2C-9BE0-2E4494F798EF

P2093

Q35072610-0207B8BC-1462-4A0D-816B-C0504BA852A0

Q35072610-0CC222A2-06A9-4C5D-8B21-B8AE1A1B448E

Q35072610-13888F04-355B-46A4-B2A2-E9CC2B85582E

Q35072610-3A68D5C0-29F3-4902-9E62-4F80E66899C9

Q35072610-6CE26768-60DC-498F-A16F-020AA22F80C4

Q35072610-C0DE7555-6943-46AF-8459-92A698D1361F

Q35072610-C462A39E-1A33-42E1-BC5F-A88132595474

P2860

Q35072610-16072638-C2CA-4FA5-9DD9-434D720CF93E

Q35072610-23D2C885-9F5E-462C-8D61-65F0DC04FB06

Q35072610-40C44D3D-05C5-4AE9-8921-B68A897BA7D8

Q35072610-40E41BDA-6211-43CA-92CA-0DB5FA9AFC36

Q35072610-4A6702F3-6D1D-4127-AF6A-C4F24A987CF0

Q35072610-5CFDA3FF-4935-43BE-9B37-8D109DFB7EA0

Q35072610-69181EEC-9EAC-4CC3-9B83-7B3D5B4E156B

Q35072610-84E41E64-1A36-446F-81DB-7257A1CCB363

Q35072610-8AB4FD6A-56D3-4649-A47C-EC23CEDE3A14

Q35072610-9D93EB3E-77DD-4A7B-A1EC-7249991275A4

P304

Q35072610-28CC800E-4C7F-4996-937E-FA7C7BF240F4

P31

Q35072610-2127026E-2D9F-42D7-89AA-327C94FDE0D6

P356

Q35072610-DAEB9A09-4C32-4DD0-A33C-9A176D0DC742

P433

Q35072610-3ACC0FD3-8066-4A31-8CCB-FE18D2F9C528

P478

Q35072610-7E5DA862-AC31-4CCC-951A-5439222D2677

P577

Q35072610-896A1148-472E-40C4-9F30-0FB61DFD877A

P698

Q35072610-1FC6AA71-452E-4B5C-8CD3-25A2C130E87F

P932

Q35072610-744D3023-46B6-4B7A-B308-0FACE294DE96

P356

P1433

Diseases of the Esophagus

P1476

Does neoadjuvant therapy for e ...... rative morbidity or mortality?

@en

P2093

A O Lidor

http://www.w3.org/2001/XMLSchema#string

B Mungo

http://www.w3.org/2001/XMLSchema#string

D Molena

http://www.w3.org/2001/XMLSchema#string

M Stem

http://www.w3.org/2001/XMLSchema#string

M V Brock

http://www.w3.org/2001/XMLSchema#string

R J Battafarano

http://www.w3.org/2001/XMLSchema#string

S C Yang

http://www.w3.org/2001/XMLSchema#string

P2860

Epidemiology of esophageal cancer

Incidence, cost, and outcomes of bleeding and chemotherapy dose modification among solid tumor patients with chemotherapy-induced thrombocytopenia.

Chemotherapy within 30 days prior to liver resection does not increase postoperative morbidity or mortality

Neoadjuvant chemotherapy for bladder cancer does not increase risk of perioperative morbidity.

Cancer and venous thromboembolism.

Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction.

Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis

Effect of neoadjuvant chemoradiotherapy on prognosis and surgery for esophageal carcinoma.

Neoadjuvant radiation therapy and its impact on complications after pancreaticoduodenectomy for pancreatic cancer: analysis of the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP).

Comparison of anastomotic leak rate after colorectal surgery using different databases.

P304

644-651

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/DOTE.12251

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P577

2014-07-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25059343

http://www.w3.org/2001/XMLSchema#string

P932

4324382

http://www.w3.org/2001/XMLSchema#string